Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Levemir (insulin detemir) and Tresiba (insulin degludec) are both long-acting insulins used to control high blood sugar levels in people with type 1 and type 2 diabetes. Levemir can be injected once or twice daily, while Tresiba is typically injected once daily and can be taken at any time of the day. Tresiba lasts longer than Levemir, with its pens being good for up to 56 days at room temperature once opened, compared to Levemir's 42 days. Levemir is available in both vials and pens, whereas Tresiba is only available in pens. Levemir has a lower risk of weight gain compared to some other insulins, but Tresiba uses one of the smallest needles possible, making injections potentially less painful. Both medications can cause low blood sugar and should not be mixed with other insulins. Tresiba is only available as a brand name, which can make it expensive. Levemir Flexpens has been discontinued as of April 2024, and vials will be discontinued by December 2024.
Levemir (insulin detemir)
Insulin degludec (Tresiba)
Levemir (insulin detemir)
Insulin degludec (Tresiba)
Summary of Levemir vs. Tresiba
Summary for Insulin
Prescription only
Levemir (insulin detemir) is a long-acting insulin that helps control high blood sugar levels in children and adults. It's injected under the skin, typically once or twice daily. Like all insulins, Levemir (insulin detemir) can raise your risk for low blood sugar, so make sure to keep fast-acting sugars with you in case your blood sugar level drops too low. This medication comes in vials. But it's also available as a Flexpen for people who have trouble drawing up insulin from the vial.
•Shakiness, hunger, and other symptoms of low blood sugar (up to 93%, depending on what other blood sugar medications you're taking)
•Common cold involving the nose, throat, and lungs (up to 27%)
•Headache (up to 23%)
•Pain or irritation of the throat (10%)
•Back pain (8%)
•Fever, chills, and other flu-like symptoms (up to 8%)
•Stomach pain (6%)
Please note: These side effects were reported by people who took Levemir (insulin detemir) for type 1 diabetes. Your risk for side effects might be different if you have type 2 diabetes.